Indrani Lall Franchini's Net Worth
$8.63 Million
Who is Indrani Lall Franchini?
Indrani Lall Franchini has an estimated net worth of $8.63 Million. This is based on reported shares across multiple companies, which include ALNYLAM PHARMACEUTICALS, INC., ALEXION PHARMACEUTICALS INC, and AVANOS MEDICAL, INC..
SEC CIK
Indrani Lall Franchini's CIK is 0001708764
Past Insider Trading and Trends
2021 was Indrani Lall Franchini's most active year for acquiring shares with 3 total transactions. Indrani Lall Franchini's most active month to acquire stocks was the month of January. 2024 was Indrani Lall Franchini's most active year for disposing of shares, totalling 10 transactions. Indrani Lall Franchini's most active month to dispose stocks was the month of January. 2020 saw Indrani Lall Franchini paying a total of $0.00 for 47,485 shares, this is the most they've acquired in one year. In 2020 Indrani Lall Franchini cashed out on 30,767 shares for a total of $4,339,879.51, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ALNYLAM PHARMACEUTICALS, INC. (ALNY) Snapshot price: $246.78
EVP, CLO & Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +15.32% | 549 |
$155.30 | -$51,094.50 | 4.13K |
Feb 27 - Feb 28
| |||
Form 4
|
∞
| 3.58K |
$170.99 | -$272,050.04 | 3.58K |
Feb 1 - Feb 2
| |||
Form 4
| -100.00% | -3.50K |
$210.00 | -$735,000.00 |
0
|
Apr 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
|
∞
| 3.5K |
$226.01 | -$378,562.51 | 3.5K |
Feb 1 - Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALEXION PHARMACEUTICALS INC No price found
EVP, Chief Compliance Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -116.08K |
—
|
—
|
0
|
Jul 21
| |||
Form 4
| +82.94% | 52.63K |
—
|
—
| 116.08K |
Jul 14
| |||
Form 4
| -1.44% | -928.00 |
$177.00 | -$164,256.00 | 63.45K |
Jun 8
| |||
Form 4
| +38.91% | 18.03K |
—
|
—
| 64.38K |
Feb 28
| |||
Form 4
| +64.24% | 18.13K |
$157.96 | -$3,133,610.48 | 46.34K |
Dec 16
| |||
Form 4
| -22.64% | -8.26K |
$114.68 | -$946,779.03 | 28.22K |
Scheduled
|
Jun 8
| ||
Form 4
| +29.24% | 8.25K |
$90.54 | -$114,714.18 | 36.47K |
Feb 28 - Mar 2
| |||
Form 4
| -4.75% | -1.41K |
$102.97 | -$144,775.82 | 28.22K |
Feb 7
| |||
Form 4
| -13.19% | -4.50K |
$132.78 | -$597,510.00 | 29.63K |
Scheduled
|
Jul 1
| ||
Form 4
| -3.95% | -1.40K |
$118.61 | -$166,528.44 | 34.13K |
Jun 7
| |||
Form 4
| +30.24% | 8.25K |
—
|
—
| 35.53K |
Feb 28
| |||
Form 4
| -2.24% | -625.00 |
$132.93 | -$83,081.25 | 27.28K |
Feb 28
| |||
Form 4
| -4.77% | -1.40K |
$119.57 | -$167,158.86 | 27.91K |
Feb 7
| |||
Form 4
| -8.16% | -2.60K |
$118.13 | -$307,728.65 | 29.3K |
Nov 28
| |||
Form 4
| -4.39% | -1.47K |
$118.53 | -$173,764.98 | 31.91K |
Jun 8
| |||
Form 4
| +33.33% | 8.34K |
—
|
—
| 33.38K |
Feb 28
| |||
Form 4
| +98.94% | 12.45K |
$116.31 | -$169,696.29 | 25.03K |
Feb 6 - Feb 8
| |||
Form 4
|
∞
| 12.58K |
—
|
—
| 12.58K |
Jun 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AVANOS MEDICAL, INC. (AVNS) Snapshot price: $23.72
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||